Wells Fargo & Company Cuts Healthcare Realty Trust (NYSE:HR) Price Target to $15.00

Healthcare Realty Trust (NYSE:HR) had its price objective dropped by equities research analysts at Wells Fargo & Company from $16.00 to $15.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “underweight” rating on the real estate investment trust’s stock. Wells Fargo & Company‘s target price would suggest a potential upside of 5.15% from the company’s previous close.

Other equities analysts have also recently issued research reports about the company. Scotiabank dropped their price objective on Healthcare Realty Trust from $18.00 to $17.00 and set a “sector perform” rating for the company in a report on Tuesday, February 25th. Wall Street Zen cut Healthcare Realty Trust from a “hold” rating to a “sell” rating in a report on Saturday. Finally, Wedbush lowered their target price on Healthcare Realty Trust from $18.00 to $16.00 and set a “neutral” rating for the company in a report on Monday, May 5th. Two equities research analysts have rated the stock with a sell rating and four have given a hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $16.80.

Healthcare Realty Trust Stock Down 0.7%

HR opened at $14.27 on Monday. The business has a fifty day moving average of $15.34 and a 200 day moving average of $16.38. Healthcare Realty Trust has a 52-week low of $14.12 and a 52-week high of $18.90. The stock has a market cap of $5.01 billion, a P/E ratio of -8.01 and a beta of 0.92.

Healthcare Realty Trust (NYSE:HR) last posted its quarterly earnings data on Thursday, May 1st. The real estate investment trust reported $0.39 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.39. Healthcare Realty Trust had a negative return on equity of 11.20% and a negative net margin of 51.60%. The company had revenue of $288.86 million during the quarter, compared to analysts’ expectations of $297.39 million. During the same quarter in the previous year, the business earned $0.39 EPS. Healthcare Realty Trust’s revenue was down 9.2% compared to the same quarter last year. Equities analysts anticipate that Healthcare Realty Trust will post 1.59 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, Director Thomas N. Bohjalian purchased 2,500 shares of Healthcare Realty Trust stock in a transaction dated Tuesday, May 13th. The stock was purchased at an average cost of $14.71 per share, with a total value of $36,775.00. Following the transaction, the director now owns 56,502 shares in the company, valued at approximately $831,144.42. The trade was a 4.63% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.37% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Golden State Wealth Management LLC bought a new position in shares of Healthcare Realty Trust in the 1st quarter worth $26,000. Blue Trust Inc. raised its position in shares of Healthcare Realty Trust by 130.3% in the 4th quarter. Blue Trust Inc. now owns 1,635 shares of the real estate investment trust’s stock worth $30,000 after acquiring an additional 925 shares in the last quarter. Smartleaf Asset Management LLC raised its position in shares of Healthcare Realty Trust by 59.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 1,650 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 612 shares in the last quarter. SVB Wealth LLC bought a new position in shares of Healthcare Realty Trust in the 1st quarter worth $35,000. Finally, Synergy Investment Management LLC bought a new position in shares of Healthcare Realty Trust in the 4th quarter worth $36,000.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust, Inc provides real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R.